WuXi Biologics CEO expects approval for Covid-19 antibody treatment 'late this year or early next year'

By CNBC2 months ago

AD

WuXi Biologics has signed more than 10 deals with clients to research antibodies that can potentially deliver treatment for the coronavirus.

Continue read on cnbc.com